A Novel Cellular Model of Pediatric and Adult BRAFV600E-mutated Papillary Thyroid Cancer

被引：0
|
作者：
O'Neill, Alison [1 ]
Medrano, Victoria Casado [1 ]
Branigan, Grace Purvis [1 ]
Salwen, Madeleine [1 ]
Bauer, Andrew [1 ]
Franco, Aime [1 ]
机构：
[1] Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2022年 / 95卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6081
引用
下载
收藏
页码：241 / 242
页数：2
相关论文
共 50 条
  • [41] Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer with Dabrafenib
    Bogsrud, Trond
    Jacobsen, Marita
    Durski, Jolanta
    Larsen, Eivind
    Engelsen, Ola
    Haskjold, Olav Inge
    Castillejo, Miguel
    Bach-Gansmo, Tore
    Van Nostrand, Douglas
    THYROID, 2023, 33 (06) : 771 - 773
  • [42] Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma
    Busch, Elena
    Kreutzfeldt, Simon
    Agaimy, Abbas
    Mechtersheimer, Gunhild
    Horak, Peter
    Brors, Benedikt
    Hutter, Barbara
    Froehlich, Martina
    Uhrig, Sebastian
    Mayer, Philipp
    Schroeck, Evelin
    Stenzinger, Albrecht
    Glimm, Hanno
    Jaeger, Dirk
    Springfeld, Christoph
    Froehling, Stefan
    Zschaebitz, Stefanie
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2020, 6 (04):
  • [43] CLINICAL PREDICTORS OF ADVERSE OUTCOMES IN 135 CHILDREN WITH BRAFV600E-MUTATED LANGERHANS CELL HISTIOCYTOSIS
    Yang, Ying
    Wang, Dong
    Ma, Honghao
    Cui, Lei
    Li, Na
    Wang, Chanjuan
    Lian, Hongyun
    Zhang, Li
    Zhao, Yunze
    Zhang, Qing
    Zhao, Xiaoxi
    Zhang, Liping
    Wang, Tianyou
    Li, Zhigang
    Zhang, Rui
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [44] Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAFV600E-mutated metastatic melanoma
    Obrador, E.
    Estrela, J. M.
    Salvador, R.
    Marchio, P.
    Valles, S. L.
    Lopez-Blanch, R.
    Benlloch, M.
    Alcacer, J.
    Perez, C. L.
    Pellicer, J. A.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S41 - S41
  • [45] Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
    Subbiah, Vivek
    Kreitman, Robert J.
    Wainberg, Zev A.
    Gazzah, Anas
    Lassen, Ulrik
    Stein, Alexander
    Wen, Patrick Y.
    Dietrich, Sascha
    de Jonge, Maja J. A.
    Blay, Jean-Yves
    Italiano, Antoine
    Yonemori, Kan
    Cho, Daniel C.
    de Vos, Filip Y. F. L.
    Moreau, Philippe
    Fernandez, Elena Elez
    Schellens, Jan H. M.
    Zielinski, Christoph C.
    Redhu, Suman
    Boran, Aislyn
    Passos, Vanessa Q.
    Ilankumaran, Palanichamy
    Bang, Yung-Jue
    NATURE MEDICINE, 2023, 29 (05) : 1103 - +
  • [46] Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
    Vivek Subbiah
    Robert J. Kreitman
    Zev A. Wainberg
    Anas Gazzah
    Ulrik Lassen
    Alexander Stein
    Patrick Y. Wen
    Sascha Dietrich
    Maja J. A. de Jonge
    Jean-Yves Blay
    Antoine Italiano
    Kan Yonemori
    Daniel C. Cho
    Filip Y. F. L. de Vos
    Philippe Moreau
    Elena Elez Fernandez
    Jan H. M. Schellens
    Christoph C. Zielinski
    Suman Redhu
    Aislyn Boran
    Vanessa Q. Passos
    Palanichamy Ilankumaran
    Yung-Jue Bang
    Nature Medicine, 2023, 29 : 1103 - 1112
  • [47] Correlation between BRAFV600E mutation and clinicopathological features in pediatric papillary thyroid carcinoma
    Jiangqiao Geng
    Huanmin Wang
    Yuanhu Liu
    Jun Tai
    Yaqiong Jin
    Jie Zhang
    Lejian He
    Libing Fu
    Hong Qin
    Yingluan Song
    Jinzhu Su
    Aiying Zhang
    Xin Wen
    Yongli Guo
    Xin Ni
    Science China Life Sciences, 2017, 60 (07) : 729 - 738
  • [48] Correlation between BRAFV600E mutation and clinicopathological features in pediatric papillary thyroid carcinoma
    Jiangqiao Geng
    Huanmin Wang
    Yuanhu Liu
    Jun Tai
    Yaqiong Jin
    Jie Zhang
    Lejian He
    Libing Fu
    Hong Qin
    Yingluan Song
    Jinzhu Su
    Aiying Zhang
    Xin Wen
    Yongli Guo
    Xin Ni
    Science China Life Sciences, 2017, 60 : 729 - 738
  • [49] Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAFV600E-mutated metastatic melanoma
    Estrela, Jose M.
    Salvador, Rosario
    Marchio, Patricia
    Valles, Soraya L.
    Lopez-Blanch, Rafael
    Rivera, Pilar
    Benlloch, Maria
    Alcacer, Javier
    Perez, Carlos L.
    Pellicer, Jose A.
    Obrador, Elena
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (12): : 2580 - +
  • [50] Low-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease
    Ruan, Gordon J.
    Hazim, Antonious
    Abeykoon, Jithma P.
    Scheckel, Caleb
    Vassallo, Robert
    Ryu, Jay H.
    Tobin, W. Oliver
    Koster, Matthew J.
    Bennani, N. Nora
    Rech, Karen L.
    Young, Jason R.
    Shah, Mithun V.
    Goyal, Gaurav
    Go, Ronald S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2733 - 2737
12345